ArticleBioinformatics advances2025
nf-core/marsseq: systematic preprocessing pipeline for MARS-seq experiments.
Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transcription factor co-expression mediates lineage priming for embryonic and extra-embryonic differentiation.Stem cell reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Single sequencing technology (scRNA-seq) enables the study of gene regulation at a single cell level. Although many sc-RNA-seq protocols have been established, they have varied in technical complexity, sequencing depth and multimodal capabilities leading to shared limitations in data interpretation due to a lack of standardized preprocessing and consistent data reproducibility. While plate based techniques such as Massively Parallel RNA Single cell Sequencing (MARS-seq2.0) provide reference data on the cells that will be sequenced, the data format limits the possible analysis. Here, we focus on the standardization of MARS-seq analysis and its applicability to RNA velocity. Results: We have taken the original MARS-seq2.0 pipeline and revised it to enable implementation using the nf-core framework. By doing so, we have simplified pipeline execution, enabling a streamlined application with increased transparency and scalability. We have incorporated additional checkpoints to verify experimental metadata and improved the pipeline by implementing a custom workflow for RNA velocity estimation. The pipeline is part of the nf-core bioinformatics community and is freely available at https://github.com/nfcore/marsseq with data analysis at https://github.com/brickmanlab/proks-et-al-2023. Availability and implementation: We introduce an updated preprocessing pipeline for MARS-seq experiments following state-of-the-art guidelines for scientific software development with the added ability to infer RNA velocity.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.